Brandywine Realty Trust (BDN) Q4 2025 Earnings Call Transcript
Brandywine Realty Trust (BDN) Q4 2025 Earnings Call Transcript
Brandywine Realty Trust (BDN) Lags Q4 FFO and Revenue Estimates
Brandywine Realty Trust (BDN) came out with quarterly funds from operations (FFO) of $0.08 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.17 per share a year ago.
Brandywine Realty Trust: Continued Declines, While Leasing Remains A Question
Brandywine Realty Trust remains under significant pressure due to declining office demand, rising capital costs, and execution missteps. BDN's pivot from life science to traditional office leasing at 3151 signals management challenges and ongoing market stress. Renewal struggles, including a 20% rent reduction in Austin, highlight deteriorating pricing power and market oversupply.
Brandywine Realty Trust (BDN) Q3 2025 Earnings Call Transcript
Brandywine Realty Trust (NYSE:BDN ) Q3 2025 Earnings Call October 23, 2025 9:00 AM EDT Company Participants Jerry Sweeney - President, CEO & Trustee Thomas E. Wirth - Executive VP & CFO George D.
Compared to Estimates, Brandywine Realty Trust (BDN) Q3 Earnings: A Look at Key Metrics
The headline numbers for Brandywine Realty Trust (BDN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Brandywine Realty Trust (BDN) Q3 FFO Lag Estimates
Brandywine Realty Trust (BDN) came out with quarterly funds from operations (FFO) of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to FFO of $0.23 per share a year ago.
Blindspots And Trade Shocks
U.S. equity markets tumbled in a sudden jolt of volatility as investors - already flying blind on key data - reacted to a surprise, massive tariff announcement on Chinese imports. The White House announced a 100% added tariff on all Chinese imports beginning next month - up from 30% currently - as retaliation to new export controls on rare minerals. The CBOE Volatility Index surged to the highest levels since mid-May in a sudden onset of angst following several months of relatively tranquil market conditions.
Brandywine Realty Trust: I'm Downgrading While Expanding My Position (Let Me Explain This Paradox)
I'm downgrading Brandywine Realty Trust due to dividend uncertainty but continue accumulating shares, seeing deep value and misunderstood upside potential. Leasing trends, asset sales at strong cap rates, and management's shift from expensive to cheaper debt support my bullish long-term thesis. Dividend coverage is not covered by free cash flow, but I prioritize capital allocation and stabilization over maintaining a high payout in turnaround situations.
Brandywine Realty Trust (BDN) Q2 2025 Earnings Call Transcript
Brandywine Realty Trust (NYSE:BDN ) Q2 2025 Earnings Conference Call July 24, 2025 9:00 AM ET Company Participants George D. Johnstone - Executive Vice President of Operations Gerard H.
Brandywine Realty Trust (BDN) Q2 FFO Lag Estimates
Brandywine Realty Trust (BDN) came out with quarterly funds from operations (FFO) of $0.15 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to FFO of $0.22 per share a year ago.
Brandywine Realty: Q2 Unlikely To Be Meaningful
Brandywine Realty Trust's high yield and discounted price reflect real risks: declining rents, shrinking FFO, and heavy debt loads. The office-heavy portfolio faces ongoing headwinds post-COVID, with management signaling asset sales and a shift toward life science and residential properties. Debt maturities loom within five years, and refinancing or asset sales may not be enough—dilution through new share issuance is a real risk.
Brandywine Realty Q1 Earnings Show Continued Stress
Brandywine Realty Trust faces significant challenges, with shares down nearly 30% YTD and a high dividend yield of over 15%. Q1 earnings reveal declining leasing activity and unsustainable cash burn, despite management's optimistic outlook and modest debt repayment. The life science market downturn exacerbates BDN's issues, with a 500,000 sq ft speculative project in Philadelphia struggling to find tenants and showing to office users.
